Orum to participate in a Hong Kong NDR, co-hosted by HSBC and Mirae Asset Securities

Event Details

Orum Therapeutics will participate in a Non-Deal Roadshow (NDR) in Hong Kong on June 12–15, 2026, co-hosted by HSBC and Mirae Asset Securities. The roadshow offers institutional investors key updates on Orum’s proprietary Degrader Antibody Conjugate (DAC) platform and strategic business initiatives. Executive leadership will host 1-on-1 sessions to discuss pipeline progression and long-term milestones.